Introduction
============

Blood cultures (BCs) are the gold standard method for the diagnosis of bacteremias. A BC isolate is considered to be a contaminant when it is not pathogenic for a patient and is introduced into the culture of the patient during either blood collection or processing ([@b1-etm-0-0-8935],[@b2-etm-0-0-8935]). Among others, contaminated BCs lead to unnecessary administration of antibiotics, prolonged hospital stay, unnecessary removal of central intravenous lines, increased work load and cost.

In the present study we aimed to evaluate the effect in the laboratory work load by stopping the processing (identification, susceptibility testing) of possible contaminant isolates by the application of a certain exclusion criterion.

Materials and methods
=====================

All BCs sent to our Laboratory from January 1, 2016 to December 31, 2017 were analyzed. All positive BCs were processed according to standard protocols and identification and susceptibility testing of the isolates were performed with Vitek2 (BioMerieux, France). Only the first isolate per species and patient was included in the study. Since the majority of the samples from the Orthopedic Department were pusses or non sterile body fluids inoculated in BC vials, all isolates from this particular Department were excluded from the analysis. As possible contaminants (from now on referred to as contaminants) were considered skin flora species including coagulase-negative *Staphylococci* (CNS), *Corynebacterium* species (sp.), *Micrococcus* sp., *Bacillus* sp. and *Propionibacterium acnes*. All viridians group *Streptococci* were always fully processed.

The two-year time period was divided into two parts: period A from January 1, 2016 to September 30, 2016 (first 9 months) and part B from October 1, 2016 to December 31, 2017 (last 15 months). During the first period all isolates including all contaminants were processed (identification/susceptibility testing) whereas in the second period among contaminants only those meeting a selection criterion were processed. This selection criterion was the presence of the same contaminant in more than one BC pairs drawn from the patient within the same day. After discussion and agreement with the clinicians a series of Departments were excluded from the application of the criterion including all Pediatric Wards, all Wards handling cancer patients along with the Nephrology and Neurology Departments. Moreover, in all cases of positive BCs with more than one isolate, including contaminant and non-contaminant isolates, all contaminants were fully processed and included in the analysis.

A series of indices (INs) were calculated. In particular: i) the Working Rate IN (WR) defined as the total isolates divided to the total number of BCs submitted per month; ii) the Contaminant Rate IN (CR) defined as the total number of contaminants processed divided to the total number of BCs submitted per month; iii) the CNS Rate (CNSR) defined as the total number of CNS processed divided to the total number of BCs submitted per month; and iv) the C/I Ratio defined as the total number of contaminants processed per month divided to the total number of isolates processed per month.

Results
=======

Over the whole period of the two years a total of 31,579 bottles were admitted and the total isolates were 2,199 (total WR: 6.96%). The total contaminants of the period were 1,028 (total CR: 3.26%) including 941 CNS (total CNSR: 2.98%), 23 *Bacillus* sp., 33 *Corynebacterium* sp., 19 *Micrococcus* sp., and 12 *Propionibacterium acnes*. CNS comprised 42.79% of the total 2,199 isolates, whereas *Bacillus* sp. comprised 1.05%, *Corynebacterium* sp. 1.5%, *Micrococcus* sp. 0.86%, and *Propionibacterium acnes* 0.55% of the total isolates. The overall C/I ratio of the period was 46.75%.

The species distribution, the number of bottles admitted, the number of isolates and contaminants processed along with the WR, the CR, the CNSR and the C/I Ratio per month and as total for period A and period B are shown in [Tables I](#tI-etm-0-0-8935){ref-type="table"} and [II](#tII-etm-0-0-8935){ref-type="table"}, respectively.

Discussion
==========

BCs remain the major tool for the diagnosis of bacteremias. Bacteremias are a significant cause of morbidity and mortality. Mortality can reach 37% as previously reported ([@b3-etm-0-0-8935]). BC contaminations are not uncommon. Despite the standard recommendation for 3% BC contamination rate usually the reports are above this level and vary significantly even reaching 12% ([@b4-etm-0-0-8935],[@b5-etm-0-0-8935]). The high fluctuation in BC contamination rate reported is partially due to the lack of uniformity since some authors decide themselves whereas others rely on the contributing microbiologist\'s decision on the contaminant status of an isolate ([@b4-etm-0-0-8935]). Despite this, the contamination rate is a significant indication of the quality provided by the hospital health-care. In the present study the overall contamination rate over the two-year period was found to be 3.26%, which is higher from the analogous indice of 2.7% previously reported from Greece ([@b6-etm-0-0-8935]). The overall CNS rate was 2.98%. CNS comprised 42.79% of total isolates, which is a slightly higher percentage than that found from a previous study in Greece (35.9%) ([@b7-etm-0-0-8935]).

Apart from the major clinical impact of BC contaminations and the relevant alteration in the clinical treatment algorithms, the overall additional cost burden due to BC contaminations is very high and is estimated as a median of \$8,720([@b8-etm-0-0-8935]). Among others this cost is due to increased length of stay (estimated as a median 4.5-day increase in North America), increased microbiology laboratory charges and increased antibiotic use ([@b4-etm-0-0-8935],[@b5-etm-0-0-8935]). In the first nine months of the present study all isolates including all possible contaminants were fully processed thus allowing the clinicians to decide themselves whether the presence of a possible contaminant in the blood was of clinical importance or not. Over the last fifteen months of the present study and in order to reduce the microbiology laboratory cost possible contaminants were only processed if they met the criterion of their presence in a second BC set of the same patient within the same day. The implementation of this criterion was easy, costless and most of all safe for the patients since the clinicians were informed immediately and their consensus was required.

In the present study, when comparing the two periods a 26.02% reduction in the CR was found (from 3.92% in period A to 2.90% in period B). An analogous percentage was recorded in the reduction of the CNSR (23.08%; from 3.51% in period A to 2.70% in period B). The overall WR was reduced from 7.19% in period A to 6.84% in period B and furthermore, the C/I Ratio was reduced from 54.50% in period A to 42.41% in period B. The reduction in all INs noted is of great value since it was achieved by the implementation of a simple, easily applicable criterion and without any cost. If more wards of the Hospital were to be included in the application of the criterion an even higher reduction would be expected and such an application is strongly advocated.
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###### 

Results of period A (January 2016 - September 2016).

  Variables                   January 2016   February 2016   March 2016   April 2016   May 2016   June 2016   July 2016   August 2016   September 2016   Total Per A
  --------------------------- -------------- --------------- ------------ ------------ ---------- ----------- ----------- ------------- ---------------- -------------
  CNS                         45             51              30           30           44         50          38          48            49               385
  *Bacillus* sp.              0              0               2            2            1          2           0           1             1                9
  *Coryne* sp.                0              0               1            2            1          3           2           3             3                15
  *Micrococcus* sp.           1              1               2            3            0          1           1           0             0                9
  *Propionibacterium acnes*   0              1               0            1            0          4           3           1             2                12
  Total contaminants          46             53              35           38           46         60          44          53            55               430
  Total bottles               1,378          1,292           1,075        1,230        1,183      1,182       1,124       1,267         1,249            10,980
  Total isolates              80             94              62           85           82         101         81          109           95               789
  Working rate (%)            5.81           7.28            5.77         6.91         6.93       8.54        7.21        8.60          7.61             7.19
  Contaminant rate (%)        3.34           4.10            3.26         3.09         3.89       5.08        3.91        4.18          4.40             3.92
  CNS rate (%)                3.27           3.95            2.79         2.44         3.72       4.23        3.38        3.79          3.92             3.51
  C/I ratio (%)               57.50          56.38           56.45        44.71        56.10      59.41       54.32       48.62         57.89            54.50

C/I, contaminants/isolates; CNS, coagulase-negative *Staphylococci*; Per, period; sp., species.

###### 

Results of period B (October 2016-December 2017).

  Variables                   October 2016   November 2016   December 2016   January 2017   February 2017   March 2017   April 2017   May 2017   June 2017   July 2017   August 2017   September 2017   October 2017   November 2017   December 2017   Total Per B
  --------------------------- -------------- --------------- --------------- -------------- --------------- ------------ ------------ ---------- ----------- ----------- ------------- ---------------- -------------- --------------- --------------- -------------
  CNS                         33             32              22              32             39              38           45           45         43          43          38            38               40             36              32              556
  *Bacillus* sp.              0              1               0               0              1               2            0            1          0           3           1             0                3              2               0               14
  *Coryne* sp.                1              0               0               2              1               0            2            0          0           0           1             0                3              1               7               18
  *Micrococcus* sp.           1              1               0               1              1               1            1            2          0           0           0             0                0              1               1               10
  *Propionibacterium acnes*   0              0               0               0              0               0            0            0          0           0           0             0                0              0               0               0
  Total contaminants          35             34              22              35             42              41           48           48         43          46          40            38               46             40              40              598
  Total bottles               1,180          1,185           1,175           1,609          1,411           1,488        1,533        1,452      1,295       1,344       1,419         1,305            1,413          1,341           1,449           20,599
  Total isolates              77             75              70              86             84              101          108          110        108         103         106           90               104            97              91              1,410
  Working rate (%)            6.53           6.33            5.96            5.34           5.95            6.79         7.05         7.58       8.34        7.66        7.47          6.90             7.36           7.23            6.28            6.84
  Contaminant rate (%)        2.97           2.87            1.87            2.18           2.98            2.76         3.13         3.31       3.32        3.42        2.82          2.91             3.26           2.98            2.76            2.90
  CNS rate (%)                2.80           2.70            1.87            1.99           2.76            2.55         2.94         3.10       3.32        3.20        2.68          2.91             2.83           2.68            2.21            2.70
  C/I ratio (%)               45.45          45.33           31.43           40.70          50.00           40.59        44.44        43.64      39.81       44.66       37.74         42.22            44.23          41.24           43.96           42.41

C/I, contaminants/isolates; CNS, coagulase-negative *Staphylococci*; Per, period; sp., species.
